Z-selective ring-closing metathesis reactions

US9446394B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9446394-B2
Application numberUS-201514641293-A
CountryUS
Kind codeB2
Filing dateMar 6, 2015
Priority dateJun 3, 2011
Publication dateSep 20, 2016
Grant dateSep 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates generally to olefin metathesis. In some embodiments, the present invention provides methods for Z-selective ring-closing metathesis.

First claim

Opening claim text (preview).

What is claimed is: 1. A metal complex of formula II-c: wherein: M is molybdenum or tungsten; R 8 is R 1 , or phenyl optionally substituted with one to five R 9 ; each R 9 is independently halogen or R 1 ; R 1 is an optionally substituted group selected from C 1-20 aliphatic, C 1-20 heteroaliphatic having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of R 2 and R 3 is independently R′, —OR′, —SR′, —N(R′) 2 , —OC(O)R′, —SOR′, —SO 2 R′, —SO 2 N(R′) 2 , —C(O)N(R′) 2 , —NR′C(O)R′, or —NR′SO 2 R′, provided that R 2 and R 3 are not simultaneously hydrogen; each R 7 is independently optionally substituted —Ar′; Ar′ is of the following formula: wherein: t is 0-4; p is 0-6; each Ring B′ and Ring C′ is independently an optionally substituted group selected from phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and each R s is independently halogen, R′, —OR′, —SR′, —S(O)R′, —S(O) 2 R′, —OSi(R′) 3 , —N(R′) 2 , —NR′C(O)R′, —NR′C(O)OR′, —NR′C(O)N(R′) 2 , —NR′SO 2 R′, —NR′SO 2 N(R′) 2 , or —NR′OR′; each R′ is independently hydrogen or an optionally substituted group selected from C 1-6 aliphatic, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, wherein: two R′ groups on the same nitrogen atom are optionally taken together with the nitrogen atom to form an optionally substituted 3-8 membered, saturated, partially unsaturated, or aryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; wherein at least one R s is —F, and the metal complex is other than 2. The metal complex of claim 1 , wherein: R 8 is substituted phenyl, wherein one or more substituents are —F. 3. A metal complex of formula II-c: wherein: M is molybdenum or tungsten; R 8 is phenyl substituted with one to five R 9 , wherein at least one R 9 is —F; each R 9 is independently halogen or R 1 ; R 1 is an optionally substituted group selected from C 1-20 aliphatic, C 1-20 heteroaliphatic having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of R 2 and R 3 is independently R′, —OR′, —SR′, —N(R′) 2 , —OC(O)R′, —SOR′, —SO 2 R′, —SO 2 N(R′) 2 , —C(O)N(R′) 2 , —NR′C(O)R′, or —NR′SO 2 R′, provided that R 2 and R 3 are not simultaneously hydrogen; each R 7 is independently an optionally substituted group selected from —Ar′, C 1-20 aliphatic, C 1-20 heteroaliphatic having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-14 membered bicyclic or tricyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and two R 7 are optionally taken together with the oxygen atoms to which they are attached to form a bidentate ligand; Ar′ is of the following formula: wherein: t is 0-4; p is 0-6; each Ring B′ and Ring C′ is independently an optionally substituted group selected from phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and each R s is independently halogen, R′, —OR′, —SR′, —S(O)R′, —S(O) 2 R′, —N(R′) 2 , —NR′C(O)R′, —NR′C(O)OR′, —NR′C(O)N(R′) 2 , —NR′SO 2 R′, —NR′SO 2 N(R′) 2 , or —NR′OR′; each R′ is independently hydrogen or an optionally substituted group selected from C 1-6 aliphatic, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10

Assignees

Inventors

Classifications

  • Carbenes or carbynes, i.e.(image) · CPC title

  • C07F11/00Primary

    Compounds containing elements of Groups 6 or 16 of the Periodic Table · CPC title

  • Cyclic compounds, e.g. cyclopentadienyls · CPC title

  • Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts · CPC title

  • Ortho-condensed systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9446394B2 cover?
The present invention relates generally to olefin metathesis. In some embodiments, the present invention provides methods for Z-selective ring-closing metathesis.
Who is the assignee on this patent?
Massachusetts Inst Technology, Trustees Boston College
What technology area does this patent fall under?
Primary CPC classification C07F11/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).